In breast cancer, miR-101 has been reported to act as a suppressor of cell proliferation by decreasing the level of DNA methyltransferase 3A (DNMT3A) and targeting proteasome maturation protein (POMP) and Stathmin 1 (Stmn1) [30, 31]. Here, DNMT3A is linked to breast carcinoma.